Australia's most trusted
source of pharma news
Posted 13 October 2021 AM
Recent leadership changes have left two coveted positions open on the Medicines Australia (MA) board and a third could be up for grabs at the end of the year.
News yesterday that GSK's VP and General Manager Christi Kelsey was leaving Australia for a new role in Belgium came just one week after MSD's VP and Managing Director Michael Azrak resigned to take up the top job heading Moderna in Australia - leaving two positions soon-to-be vacant.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.